SOCS3 is an endogenous inhibitor of pathologic angiogenesisSTAHL, Andreas; JOYAL, Jean-Sebastian; DENNISON, Roberta J et al.Blood. 2012, Vol 120, Num 14, pp 2925-2929, issn 0006-4971, 5 p.Article

The negative regulatory roles of suppressor of cytokine signaling proteins in myeloid signaling pathwaysWORMALD, Samuel; HILTON, Douglas J.Current opinion in hematology. 2007, Vol 14, Num 1, pp 9-15, issn 1065-6251, 7 p.Article

Suppressor of cytokine signaling gene expression in human pancreatic islets : modulation by cytokinesSANTANGELO, Carmela; SCIPIONI, Angela; MARSELLI, Lorella et al.European journal of endocrinology. 2005, Vol 152, Num 3, pp 485-489, issn 0804-4643, 5 p.Article

Serum amyloid A overrides T_reg anergy via monocyte-dependent and T_reg-intrinsic, SOCS3-associated pathwaysNGUYEN, Khoa D; MACAUBAS, Claudia; NADEAU, Kari C et al.Blood. 2011, Vol 117, Num 14, pp 3793-3798, issn 0006-4971, 6 p.Article

SOCS3 promotes interleukin-17 expression of human T cellsKLEINSTEUBER, Katja; HEESCH, Kerrin; SCHATTLING, Stefanie et al.Blood. 2012, Vol 120, Num 22, pp 4374-4382, issn 0006-4971, 9 p.Article

Involvement of suppressors of cytokine signaling in toll-like receptor- : mediated block of dendritic cell differentiation. CommentaryNAIK, Ulhas P; BARTZ, Holger; AVALOS, Nicole M et al.Blood. 2006, Vol 108, Num 13, issn 0006-4971, 3959-3960,4102-4108 [9 p.]Article

Methylation status of the SOCS3 gene in human malignant melanomasTOKITA, Tomoko; MAESAWA, Chihaya; KIMURA, Toshimoto et al.International journal of oncology. 2007, Vol 30, Num 3, pp 689-694, issn 1019-6439, 6 p.Article

SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockadePELLO, Oscar M; MORENO-ORTIZ, Maria Del Carmen; BERNAD, Antonio et al.Blood. 2006, Vol 108, Num 12, pp 3928-3937, issn 0006-4971, 10 p.Article

Modulation of Janus kinase 2 by cisplatin in cancer cellsHUI SONG; SONDAK, Vernon K; BARBER, Dwayne L et al.International journal of oncology. 2004, Vol 24, Num 4, pp 1017-1026, issn 1019-6439, 10 p.Article

Gigantism in mice lacking suppressor of cytokine signalling-2METCALF, D; GREENHALGH, C. J; VINEY, E et al.Nature (London). 2000, Vol 405, Num 6790, pp 1069-1073, issn 0028-0836Article

Role of SOCS1 in tumor progression and therapeutic applicationJING ZHANG; HUI LI; YU, Jin-Pu et al.International journal of cancer (Print). 2012, Vol 130, Num 9, pp 1971-1980, issn 0020-7136, 10 p.Article

Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformationCOOPER, John C; MINGJIAN SHI; CHUEH, Fu-Yu et al.International journal of oncology. 2010, Vol 36, Num 5, pp 1201-1208, issn 1019-6439, 8 p.Article

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disordersFOUROUCLAS, Nasios; JUAN LI; GREEN, Anthony R et al.Haematologica (Roma). 2008, Vol 93, Num 11, pp 1635-1644, issn 0390-6078, 10 p.Article

SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetesBARRAL, Ana Maria; THOMAS, Helen E; LING, Eleanor M et al.Journal of autoimmunity (Print). 2006, Vol 27, Num 3, pp 166-173, issn 0896-8411, 8 p.Article

Phospholipase Cγ1 is required for activation of store-operated channels in human keratinocytesTU, Chia-Ling; WENHAN CHANG; BIKLE, Daniel D et al.Journal of investigative dermatology. 2005, Vol 124, Num 1, pp 187-197, issn 0022-202X, 11 p.Article

Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytesYAMASAKI, Kenshi; HANAKAWA, Yasushi; TOKUMARU, Sho et al.Journal of investigative dermatology. 2003, Vol 120, Num 4, pp 571-580, issn 0022-202X, 10 p.Article

SOCS3 regulates graft-versus-host diseaseHILL, Geoffrey R; KUNS, Rachel D; ROBERTS, Andrew W et al.Blood. 2010, Vol 116, Num 2, pp 287-296, issn 0006-4971, 10 p.Article

Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cellsTAKAHASHI, Yuki; KANEDA, Haruka; TAKASUKA, Nana et al.Cancer science. 2008, Vol 99, Num 8, pp 1650-1655, issn 1347-9032, 6 p.Article

SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer GrowthBERGER, Hélène; VEGRAN, Frédérique; CHEVRIAUX, Angélique et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 12, pp 3578-3590, issn 0008-5472, 13 p.Article

Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-αTOMITA, Shintaro; ISHIBASHI, Kei; YAMAGUCHI, Osamu et al.Cancer science. 2011, Vol 102, Num 1, pp 57-63, issn 1347-9032, 7 p.Article

Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3ZHUOHAN ZHANG; QIAOFEI LIU; YUAN ZHANG et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 1, pp 89-98, issn 0008-5472, 10 p.Article

Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammationHASHIMOTO, Masayuki; AYADA, Toranoshin; KINJYO, Ichiko et al.Cancer science. 2009, Vol 100, Num 4, pp 730-736, issn 1347-9032, 7 p.Article

The molecular physiology of CRAC channelsPRAKRIYA, Murali.Immunological reviews. 2009, Vol 231, pp 88-98, issn 0105-2896, 11 p.Article

Orail-STIM1 formed store-operated Ca²⁺ channels (SOCs) as the molecular components needed for Pb²⁺ entry in living cellsCHANG, Yu-Fen; TENG, Hsiao-Chuan; CHENG, Sha-Yen et al.Toxicology and applied pharmacology. 2008, Vol 227, Num 3, pp 430-439, issn 0041-008X, 10 p.Article

SOCS in situ expression in tuberculous lymphadenitis in an endemic areaNICOL, A. F; NUOVO, G. J; COELHO, J. M. C et al.Experimental and molecular pathology. 2008, Vol 84, Num 3, pp 240-244, issn 0014-4800, 5 p.Article